Achieve Life Sciences, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Achieve Life Sciences, Inc. (ACHV) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$54.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-24
- Achieve Life Sciences, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$54.19M.
- Achieve Life Sciences, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$39.53M.
- Achieve Life Sciences, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$28.98M.
- Achieve Life Sciences, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$41.66M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$54.19M 10-K · filed 2026-03-24 |
| 2024-12-31 | -$39.53M 10-K · filed 2026-03-24 |
| 2023-12-31 | -$28.98M 10-K · filed 2026-03-24 |
| 2022-12-31 | -$41.66M 10-K · filed 2025-03-11 |
| 2021-12-31 | -$31.41M 10-K · filed 2024-03-28 |
| 2020-12-31 | -$12.30M 10-K · filed 2023-03-16 |
| 2019-12-31 | -$10.03M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |